The global wound care market size was valued at USD 20.6 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 4.1% from 2022 to 2030. The demand for wound care products is increasing owing to the increasing number of surgical cases, and the rising prevalence of chronic diseases across the globe. Furthermore, the increasing incidence of diabetes due to sedentary lifestyles is one of the leading factors contributing to market growth. For instance, according to American Diabetes Association, in 2018, an estimated 34.2 million people, i.e., 10.5% of the total U.S. population, had diabetes. Moreover, nearly 1.6 million U.S. residents had type 1 diabetes, which includes about 187,000 adolescents and children.
Wound care products help to cure diabetic foot ulcers, which are prevalent in diabetic patients. For instance, according to ScienceDirect, diabetic foot ulcers may affect more than 25% of the diabetic population and may lead to amputation of the foot in 20% of patients. Wound care products such as hydrocolloid dressings help in moisture retention and allow rapid healing of wounds internally as well as externally. Moreover, these products help in the absorption of necrotic tissues, which are effective in cases of surgical site infections. Thus, healthcare professionals prefer to use wound care products, which is anticipated to propel the market growth during the forecast period.
The advanced wound dressings segment held the largest revenue share in 2021. One of the key factors responsible for its dominance is an increase in the number of burn cases. For instance, as per the American Burn Association (ABA) in 2016, around 486,000 people were given medical treatment due to burn injuries in the U.S. It also reported that complications of infection have accounted to be highest in burn patients. Additionally, the increasing geriatric population base is another major factor accelerating market growth. For instance, as per the United Nations Organization, the geriatric population numbered over 962.0 million in 2017 and is projected to reach around 2.1 billion by 2050. The geriatric population is more susceptible to wounds, and therefore, may help propel the market during the forecast period.
Moreover, the increasing number of Ambulatory Surgical Centers (ASCs) is expected to drive the market for wound care. ASCs offer a variety of services such as surgical care, diagnostics, and preventive procedures. Surgeries for pain management, urology, orthopedics, restorative, reconstructive, or alterative plastic surgeries, and Gastro-Intestinal (GI) related surgeries are also performed in ambulatory surgery centers. In addition, ASCs are increasing in number and thus offer cost-effective services. For instance, according to Advancing Surgical Care, as of March 2021, the number of ASCs in the U.S. is estimated to be 6,023. Thus, with the increasing number of ASCs, the market is expected to propel during the forecast period.
Furthermore, the increasing number of traumatic injuries across the globe is expected to propel the market for wound care. For instance, as per WHO (2018), around 1,000,000 people are severely or moderately burnt in India per year. In addition, as per NCBI, in 2017, countries such as Bulgaria, Finland, the Netherlands, China, Australia, and the U.K. reported a rise in the incidence of burn wounds. As per the WHO, each year, an estimated 22,941 individuals die in Thailand as a result of traffic-related incidents, accounting for roughly 33% of all deaths in the country. Collagenase-based enzymatic wound debridement products are majorly used for the treatment of such acute wounds. Thus, such cases are expected to increase the demand for wound care products.
COVID-19 considerably decreased the need for wound care products around the globe. However, with the development of vaccines, countries have opened their international borders; as a result, the market is expected to impel post-COVID-19. The earlier postponed elective surgeries are expected to be completed during the post-pandemic time, thereby increasing the use of wound care products. Many companies are incorporating various strategies such as product launches, mergers and acquisitions, collaborations, and expansion to meet the demand. For instance, in October 2021, Medline Industries launched its Post-Acute Infection Prevention Program. This will be a consultative program, which is focused on post-acute infection prevention. This helped the company to penetrate its products among the population. Similarly, in 2021, Mölnlycke announced the launch of a new U.K. distribution center. This helped the company strengthen customer access to quality Mölnlycke products.
The advanced wound dressing segment dominated the market for wound care and held the maximum revenue share of 34.6% in 2021 and is expected to register the highest CAGR during the forecast period. Advanced wound dressing is majorly used for the treatment of chronic and non-healing wounds. Thus, an increase in the number of chronic wounds such as diabetic foot ulcers is expected to help the market propel. For instance, as per The Independent Diabetes Trust, at any given time, 115,000 people in the U.K. may develop a diabetic foot ulcer, whereas, 278,000 people are treated with venous leg ulcers every year. These wounds take an average of 200 days to heal. Therefore, due to the aforementioned factors, the market for wound care is expected to progress during the forecast period.
The surgical wound care segment is anticipated to witness a considerable growth rate of 4.3% during the forecast period. This can be attributed to rising surgical cases and surgical site infections worldwide. For instance, as per the National Healthcare Safety Network (NHSN) Surgical Site Infection Surveillance in 2018, around 157,500 cases of SSIs are reported every year in the U.S. Thus, impelling the segment growth.
The chronic wounds segment dominated the market for wound care and held the largest revenue share of 59.9% in 2021 and is anticipated to witness considerable growth during the forecast period. The increasing geriatric population, along with the rising prevalence of diabetic foot ulcers, venous pressure ulcers, and other chronic wounds is expected to drive the segment growth. For instance, according to the Administration for Community Living’s profile on older Americans, the U.S. population aged 65 and above was expected to be 54.1 million in 2019, which is about 19% of the U.S. population. This population increased by about 36% from 2009 to 2019 and is projected to reach 80.8 million by 2040, and 94.7 million by 2060. Furthermore, the number of people suffering from varicose veins in the U.S. is increasing on a year-on-year basis. For instance, according to the Journal of the American Heart Association, approximately 23% i.e., 1 in every 4 U.S. residents have varicose veins. An increase in the number of varicose veins may lead to the development of venous leg ulcers, thus driving the market.
The acute wound segment is expected to witness the fastest CAGR of 4.24% during the forecast period. The increasing cases of different traumatic wounds and burns is the major factor driving the segment growth. The multiple benefits of acute wound products include reduced surgical site infections, improved results & patient satisfaction, and reduced hospital stays. There is also an increase in the number of burn wounds across the globe. Since acute wound products are majorly used for treating acute wounds such as traumatic wounds, the use of wound care products is expected to help surge the segment growth.
The hospital segment dominated the market for wound care and held the largest revenue share of 45.3% in 2021. The growth of this segment can be attributed to an upsurge in surgical procedures globally because of sedentary lifestyles, and rising bariatric surgeries which require the use of wound care products to contain surgical site infections. Furthermore, surgical wound care dressings and NPWT are predominantly suitable for hospital use and are not feasible for homecare. In addition, hospital institutions are considered to be large buyers of wound care products, having long-term contracts with suppliers. Hence, owing to the aforementioned factors, the segment is anticipated to propel during the forecast period.
In addition, the increase in hospital admissions due to surgeries is also anticipated to propel the segment growth over the forecast period. Patients after surgery generally require wound care products to heal from surgical site wounds. Therefore, the segment is expected to witness significant growth during the projection period. The home healthcare segment is expected to witness the fastest CAGR of 4.9% during the forecast period. During the pandemic, home healthcare wound care products were more in demand. Wound care in the home care setting is majorly initiated with the introduction of single-use NPWT systems. These devices are lightweight, portable, canister-free, and easy to use.
In addition, the cost-effectiveness of such therapy for treating wounds also encourages patients to adopt homecare settings over hospital stays. Moreover, an increasing geriatric population is expected to propel the segment. The geriatric population tends to opt for home care settings or nursing home care. Furthermore, the presence of several organizations offering home care services in North America and Europe is promoting the home care services market. Thus, with an increase in the geriatric population and nursing home care, the segment is anticipated to impel during the forecast period.
North America dominated the wound care market and accounted for a revenue share of 45.4% in 2021 and is expected to witness considerable growth over the forecast period. The presence of a large population base and rising patient pool in countries such as the U.S. are major factors driving the market growth in this region. Moreover, the geriatric population is at a higher risk of wounds, which will surge the demand for wound care products in this region. For instance, as per the Administration for Community Living, on aging and health, the percentage of people aged 65 and above was 54.1 million in 2019, which represents 16% of the population. Additionally, the increasing number of road accidents and availability of skilled professionals in this region is expected to drive the demand for wound care products in North America.
In Asia Pacific, the market is estimated to witness the highest CAGR of 4.8% over the forecast period. This can be attributed to the changing lifestyle leading to an increase in the incidence of chronic diseases in this region. For instance, according to the Down to Earth organization, as of December 2021, India had 74.2 million diabetic patients aged 20-79. Moreover, the number is expected to increase to 124.8 million by 2045. Furthermore, medical tourism in this region is increasing, which is driving the number of surgeries performed. Thus, owing to the above-mentioned factors, Asia Pacific is anticipated to witness the fastest growth rate during the forecast period.
The market is highly fragmented in nature with the presence of several small and large manufacturers. Competitive rivalry and the degree of competition in the wound care market are expected to intensify during the forecast period due to the presence of many players in the market. Furthermore, leading players are involved in collaborations, product launches, and mergers and acquisitions to strengthen their product portfolios. For instance, in March 2020, Smith and Nephew launched a novel PICO 14 NPWT system that has a pump duration of up to 14 days. This product launch helped the company in expanding its product offerings. Similarly, in September 2019, the company acquired Southlake Medical Supplies for approximately USD 5 million. This helped the company strengthen its presence in the U.S. market. Thus, with various strategies acquired by leading players, the market is expected to impel during the forecast period. Some of the prominent players in the wound care market include:
Smith & Nephew
Mölnlycke Health Care AB
ConvaTec Group PLC
Ethicon (Johnson & Johnson)
Derma Sciences Inc. (Integra LifeSciences)
Market size value in 2022
USD 21.4 billion
Revenue forecast in 2030
USD 29.6 billion
CAGR of 4.1% from 2022 to 2030
Base year for estimation
2018 - 2020
2022 - 2030
Revenue in USD million and CAGR from 2022 to 2030
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Product, application, end-use, region
North America; Europe; Asia Pacific; Latin America; Middle East & Africa (MEA)
U.S.; Canada; U.K.; Germany; France; Italy; Netherlands; Spain; Sweden; Japan; China; India; South Korea; Taiwan; Australia; Vietnam; Thailand; Malaysia; Singapore; Indonesia; Philippines; Brazil; Mexico; Argentina; South Africa; Turkey; Egypt; Iran; Israel; Saudi Arabia; UAE
Key companies profiled
Smith & Nephew; Mölnlycke Health Care AB; ConvaTec Group PLC; Ethicon (Johnson & Johnson); Baxter International; URGO Medical; Coloplast Corp.; Medtronic; 3M; Derma Sciences Inc. (Integra LifeSciences).
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global wound care market report on the basis of product, application, end-use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Advanced Wound Dressing
Other Advanced Dressings
Surgical Wound Care
Sutures & staples
Tissue adhesive and sealants
Traditional Wound Care
Wound Therapy Devices
Negative pressure wound therapy
Oxygen and hyperbaric oxygen equipment
Electric stimulation devices
Pressure relief devices
Application Outlook (Revenue, USD Million, 2018 - 2030)
Diabetic foot ulcers
Venous leg ulcers
Other chronic wounds
Surgical & traumatic wounds
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Regional Outlook (Revenue, USD Million, 2018 - 2030)
Middle East & Africa
b. The global wound care market size was estimated at USD 20.6 billion in 2021 and is expected to reach USD 21.4 billion in 2022.
b. The global wound care market is expected to grow at a compound annual growth rate of 4.1% from 2022 to 2030 to reach USD 29.6 billion by 2030.
b. The advanced wound dressing dominated the wound care market in 2021 with a market share of 34.55% and is expected to witness the fastest growth over the forecast period due to an increase in technological advancement, rising cases of chronic diseases, and an increase in the number of sports-related injuries.
b. Some key players operating in the wound care market include Smith & Nephew PLC, MÃ¶lnlycke Health Care AB, ConvaTec Group PLC, Ethicon (Johnson & Johnson), Baxter International, URGO Medical, Coloplast Corp., Medtronic, 3M, and Derma Sciences, (Integra LifeSciences)
b. Key factors that are driving the wound care market growth include the increasing prevalence of diabetes, the increase in a number of surgical procedures, and changing lifestyles are anticipated to drive the growth of the wound care market.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.
"The quality of research they have done for us has been excellent."
With COVID-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for COVID-19 as a key market contributor.